Deutsche Bank Downgrades Medley Management (MDLY) to Hold
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Deutsche Bank downgraded Medley Management (NYSE: MDLY) from Buy to Hold with a price target of $10.50 (from $9.00). The downgrade was tied to valuation.
"Medley Management (MDLY) reported 3Q results that were slightly below our expectations, as core EPS of 14c missed our estimate by 2c while fee earning AUM declined 1.5% to $3.1 billion. We are trimming our 2016 estimate slightly but we are increasing our 2017 estimate given our revised AUM growth assumptions. As a result, we are increasing our target to $10.50 per share, which is based on 12x our 2017 core EPS estimate. However, given the valuation relative to our new target, we are lowering our rating to a Hold," said analyst Stephen Laws.
Shares of Medley Management closed at $10.40 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- M&T Bank (MTB) PT Raised to $165 at FBR Capital Following 4Q Beat
- PacWest Bancorp (PACW) PT Raised to $60.50 at FIG Partners Following 4Q Report
- Deutsche Bank Sees 'Encouraging' Short-Term Set-Up in Valeant (VRX)
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS View, Downgrades
Related EntitiesDeutsche Bank
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!